Differential Diagnosis and Management of Suprasellar Tumors and of Supratentorial Tumors (May 22, 2024)

This event has passed and can no longer be viewed

This event was presented live or live-streamed and has not been designated for on-demand presentation.

This Pediatric Neuro-Oncology Tumor Boards Series session will take place on Wednesday, May 22, 2024 at 7:00 a.m. This series is restricted to participants of the tumor board and will not be broadcast.

Activity Information

Needs Statement

Faculty, fellows, residents, and other healthcare professionals in pediatric neuro-oncology need to receive regular updates regarding advances in the multi-disciplinary strategies used to treat brain and other central nervous system tumors in children. The tumor board aims to increase knowledge of the learners in the topic areas discussed, and encourages learners to implement current clinical practice guidelines and advanced treatment strategies to enhance the quality of patient care and outcomes.

Educational Objectives

At the conclusion of the sessions, the participants should be able to:

  • Examine the importance of an integrated multi-disciplinary approach to the management of children with brain tumors and incorporate into clinical practice.
  • Explain the rationale for specific tests for the diagnosis and management of pediatric brain tumors.
  • Discuss the design of various phases of clinical trials, and compare the significance of early phase clinical trials versus phase 3 clinical trials.
  • Evaluate the various therapeutic interventions for brain tumors, particularly with reference to neurosurgery, chemotherapy, and radiation therapy.

Target Audience

Professional Categories

  • Physicians
  • Fellows
  • Residents
  • Nurses
  • Other Health Professionals

Specialties

  • Neurosurgery
  • Oncology
  • Pediatrics

Interest Groups

  • Hospital Medicine

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Director

  1. Murali Chintagumpala, M.B.B.S.

    Murali Chintagumpala, M.B.B.S.

    Professor
    Baylor College of Medicine

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenters

  1. Guillermo Aldave, M.D.

    Guillermo Aldave, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Melissa M. Blessing, D.O.

    Melissa M. Blessing, D.O.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Daniel Curry, M.D.

    Daniel Curry, M.D.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Karen Moeller, M.D. Placeholder Image

    Karen Moeller, M.D.

    Associate Professor of Pediatrics, Section of Neuro-radiology
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. William Whitehead, M.D.

    William Whitehead, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Activity Director

  1. Murali Chintagumpala, M.B.B.S.

    Murali Chintagumpala, M.B.B.S.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Murali Chintagumpala, M.B.B.S.

    Murali Chintagumpala, M.B.B.S.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Frank Lin, M.D., Ph.D. Placeholder Image

    Frank Lin, M.D., Ph.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. Mehmet Fatih Okcu, M.D.

    Mehmet Fatih Okcu, M.D.

    Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Surya Rednam, M.D.

    Surya Rednam, M.D.

    Assistant Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Austin Stuckert, M.D. Placeholder Image

    Austin Stuckert, M.D.

    Pediatrics Resident
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Presenters:

Guillermo Aldave, M.D.

Guillermo Aldave, M.D.

Assistant Professor Baylor College of Medicine
Melissa M. Blessing, D.O.

Melissa M. Blessing, D.O.

Assistant Professor Baylor College of Medicine
Daniel Curry, M.D.

Daniel Curry, M.D.

Associate Professor Baylor College of Medicine

Karen Moeller, M.D.

Associate Professor of Pediatrics, Section of Neuro-radiology Baylor College of Medicine
William Whitehead, M.D.

William Whitehead, M.D.

Professor Baylor College of Medicine

Health Topics

You May Also Be Interested In

Upcoming
Melanoma, Skin Cancer, and Sarcoma Tumor Board
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Melanoma, Skin Cancer, and Sarcoma Tumor Board
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available
Upcoming
Dan L Duncan Cancer Center–The Woodlands Weekly Tumor Board
Activity duration: 1 hr
Credit 1.00 Continuing Medical Education Credits Available